NCT05405751CompletedPhase 4
Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED)
Simplified Model of Linkage and Retention to Healthcare System, Using a Mobil Unit and a Same-day Test and Treat Approach Among Excluded Population.
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
Implementation of a model for access and retention of HIV care for vulnerable and excluded population using a mobile screening unit and a strategy of diagnosis and initiation of treatment with Bictegravir (BIC) 50 mg/ Emtricitabine (FTC) 200 mg / Tenofovir Alafenamide (TAF) 25 mg.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 27 Apr 2022
- Start date
- 4 Jul 2022
- Primary completion date
- 26 Dec 2023
- Lead sponsor
- Fundacion SEIMC-GESIDA
- Diseases
- HIV
- NCT number
- NCT05405751
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 101
- From 4 Jul 2022 to the primary completion date, 26 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of allergy to any of the following drugs: bictegravir, tenofovir alafenamide or emtricitabine
- Suspected or diagnosed of active opportinistic disease
- History of severe liver disease (Child- Pugh C) or history of descompensated liver disease (defined as the presence of ascites, encephalopathy, coagulopathy, hypoalbuminaemia, oesophageal or gastric varices or persistent jaundice)
- History of kidney disease CKP-EPI\< 30ml/min
- Have any condition that, as per investigator criteria, makes the patient not candidate to be included (active disease, social situation, intoxication...)
Other
- Unable to provide contact details
- Taking antiretroviral treatment for less than 1 month
- Pregnancy or breastfeeding at the time of screening or gestational desires during the study period.
Who the study is looking for
- Vulnerable person ≥18 years
- Understand and sign the informed consent form
- Confirmed HIV infection
- Not receiving ART or on ART with a PVL \> copies/ml
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| H. Infanta Leonor Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.